PARTITIONBIO LTD

Active Helions Bumpstead

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PARTITIONBIO LTD

Research and experimental development on biotechnology

Founded 26 May 2021 Active Helions Bumpstead, England 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

BIOFAZE LTD 26 May 2021 — 25 May 2023
Accounts Submitted 10 Mar 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 7 Nov 2025 Next due 14 Nov 2026 6 months remaining
Net assets £406K £477K 2024 year on year
Total assets £989K £26K 2024 year on year
Total Liabilities £583K £502K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Helions Farm Sages End Road Helions Bumpstead Essex CB9 7AW England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PARTITIONBIO LTD (13421275), an active life sciences and medical technology company based in Helions Bumpstead, England. Incorporated 26 May 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£425.96k

Increased by £78.09k (+22%)

Net Assets

£406.12k

Decreased by £476.90k (-54%)

Total Liabilities

£583.24k

Increased by £502.44k (+622%)

Turnover

N/A

Employees

9

Decreased by 1 (-10%)

Debt Ratio

59%

Increased by 51 (+638%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 31,152 Shares £2.86m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Dec 2023835£150k£179.66
13 Nov 202379£7k£89.6
26 Sept 2023835£150k£179.66
12 Sept 20231,670£300k£179.66
14 Jan 20229,355£2.10m£224.58

Officers

Officers

2 active 1 resigned
Status
Niall Antony ArmesDirectorBritishEngland5626 May 2021Active
Olaf PiepenburgDirectorBritishUnited Kingdom5519 Jan 2022Active

Shareholders

Shareholders (28)

Dr Niall Antony Armes
40.2%
14,491
Mrs Helen Kent-armes
15.9%
5,726

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Niall Antony Armes

British

Active
Notified 26 May 2021
Residence England
DOB January 1970
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026AccountsAnnual accounts made up to 30 Jun 2025
3 Feb 2026OfficersChange to director Dr Olaf Piepenburg on 19 Jan 2022
19 Nov 2025Persons With Significant ControlChange to Dr Niall Antony Armes as a person with significant control on 12 Sept 2023
18 Nov 2025CapitalAllotment of shares (GBP 360.86) on 19 Sept 2025
7 Nov 2025Confirmation StatementConfirmation statement made on 31 Oct 2025 with updates
10 Mar 2026 Accounts

Annual accounts made up to 30 Jun 2025

3 Feb 2026 Officers

Change to director Dr Olaf Piepenburg on 19 Jan 2022

19 Nov 2025 Persons With Significant Control

Change to Dr Niall Antony Armes as a person with significant control on 12 Sept 2023

18 Nov 2025 Capital

Allotment of shares (GBP 360.86) on 19 Sept 2025

7 Nov 2025 Confirmation Statement

Confirmation statement made on 31 Oct 2025 with updates

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

1 months ago on 10 Mar 2026

Change to director Dr Olaf Piepenburg on 19 Jan 2022

2 months ago on 3 Feb 2026

Change to Dr Niall Antony Armes as a person with significant control on 12 Sept 2023

5 months ago on 19 Nov 2025

Allotment of shares (GBP 360.86) on 19 Sept 2025

5 months ago on 18 Nov 2025

Confirmation statement made on 31 Oct 2025 with updates

5 months ago on 7 Nov 2025